TFA
TEVA icon

Toth Financial Advisory’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Toth Financial Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-35
Closed -$1.19K – 1096
2026
Q2 		$1.19K Buy
35
+30
+600% +$999 ﹤0.01% 808
2026
Q1 		$151 Hold
5
– – ﹤0.01% 883
2025
Q4 		$157 Buy
+5
New +$123 ﹤0.01% 865

Other funds holding TEVA

WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
VEM
Vann Equity Management Plano, Texas $168M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Toth Financial Advisory's TEVA Position: Q3 2026 in Review

Toth Financial Advisory sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 35 shares — an estimated $1.19K sold.

Toth Financial Advisory first reported a position in TEVA in Q4 2025 and held it in 3 quarters. The position peaked at $1.19K in Q2 2026. 10 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Toth Financial Advisory reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
  • Toth Financial Advisory sold 35 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $1.19K.
  • Toth Financial Advisory first reported a position in Teva Pharmaceutical Industries Limited in Q4 2025 and held it in 3 quarters.
  • Toth Financial Advisory's Teva Pharmaceutical Industries Limited position peaked at $1.19K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.